WallStreetZenWallStreetZen

NASDAQ: ACRS
Aclaris Therapeutics Inc Stock

Buy ACRS
$16.88+0.12 (+0.72%)
Updated Aug 16, 2022
ACRS Price
$16.88
Fair Value Price
$17.91
Market Cap
$1.13B
52 Week Low
$9.26
52 Week High
$19.97
P/E
-12.6x
P/B
4.77x
P/S
150.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$6.14M
Earnings
-$83.27M
Gross Margin
27.2%
Operating Margin
-1,355.98%
Profit Margin
-1,356%
Debt to Equity
0.18
Operating Cash Flow
-$68M
Beta
0.99
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

ACRS Overview

Zen Score

Industry Average (29)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ACRS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ACRS ($16.88) is undervalued by 5.77% relative to our estimate of its Fair Value price of $17.91 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
ACRS ($16.88) is not significantly undervalued (5.77%) relative to our estimate of its Fair Value price of $17.91 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ACRS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ACRS due diligence checks available for Premium users.

ACRS News

Valuation

ACRS fair value

Fair Value of ACRS stock based on Discounted Cash Flow (DCF)
Price
$16.88
Fair Value
$17.91
Undervalued by
5.77%
ACRS ($16.88) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ACRS ($16.88) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ACRS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ACRS price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-12.6x
Industry
15.64x
Market
32.28x

ACRS price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.77x
Industry
4.91x
ACRS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ACRS's financial health

Profit margin

Revenue
$1.5M
Net Income
-$20.5M
Profit Margin
-1,343.7%
ACRS's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
ACRS's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$278.0M
Liabilities
$42.2M
Debt to equity
0.18
ACRS's short-term assets ($259.35M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ACRS's short-term assets ($259.35M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ACRS's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ACRS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$19.7M
Investing
-$21.2M
Financing
$72.8M
ACRS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ACRS vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ACRS$1.13B+0.72%-12.60x4.77x
MRUS$1.13B-4.39%-19.06x3.45x
TGTX$1.13B-7.38%-3.60x8.76x
SRNE$1.13B-8.36%-1.65x8.59x
RNA$1.14B-1.44%-6.95x3.05x

Aclaris Therapeutics Stock FAQ

What is Aclaris Therapeutics's quote symbol?

NASDAQ: ACRS) Aclaris Therapeutics trades on the NASDAQ under the ticker symbol ACRS. Aclaris Therapeutics stock quotes can also be displayed as NASDAQ: ACRS.

If you're new to stock investing, here's how to buy Aclaris Therapeutics stock.

What is the 52 week high and low for Aclaris Therapeutics (NASDAQ: ACRS)?

(NASDAQ: ACRS) Aclaris Therapeutics's 52-week high was $19.97, and its 52-week low was $9.26. It is currently -15.47% from its 52-week high and 82.29% from its 52-week low.

How much is Aclaris Therapeutics stock worth today?

(NASDAQ: ACRS) Aclaris Therapeutics currently has 66,671,750 outstanding shares. With Aclaris Therapeutics stock trading at $16.88 per share, the total value of Aclaris Therapeutics stock (market capitalization) is $1.13B.

Aclaris Therapeutics stock was originally listed at a price of $11.05 in Oct 7, 2015. If you had invested in Aclaris Therapeutics stock at $11.05, your return over the last 6 years would have been 52.76%, for an annualized return of 7.32% (not including any dividends or dividend reinvestments).

How much is Aclaris Therapeutics's stock price per share?

(NASDAQ: ACRS) Aclaris Therapeutics stock price per share is $16.88 today (as of Aug 16, 2022).

What is Aclaris Therapeutics's Market Cap?

(NASDAQ: ACRS) Aclaris Therapeutics's market cap is $1.13B, as of Aug 17, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Aclaris Therapeutics's market cap is calculated by multiplying ACRS's current stock price of $16.88 by ACRS's total outstanding shares of 66,671,750.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.